These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38590014)

  • 41. Primary intrafascial desmoplastic melanoma with pseudoglandular differentiation and aberrant cytokeratins expression: An exceptional presentation.
    Saggini A; Cerroni L; Casini B; Baciorri F; Cota C
    Pathol Res Pract; 2019 Dec; 215(12):152668. PubMed ID: 31585813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular testing in melanoma for the surgical pathologist.
    Andea AA
    Pathology; 2023 Mar; 55(2):245-257. PubMed ID: 36653236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
    Kiavash K; Bluth MH; Thompson AD
    Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanocytic lesions - Staying out of trouble.
    Brenn T
    Ann Diagn Pathol; 2018 Dec; 37():91-102. PubMed ID: 30312883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 48. Histopathologic features of melanoma in difficult-to-diagnose lesions: A case-control study.
    Gonzalez ML; Young ED; Bush J; McKenzie K; Hunt E; Tonkovic-Capin V; Jacobs M; Kucenic M; Fraga GR
    J Am Acad Dermatol; 2017 Sep; 77(3):543-548.e1. PubMed ID: 28601392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
    Busam KJ; Zhao H; Coit DG; Kucukgol D; Jungbluth AA; Nobrega J; Viale A
    J Invest Dermatol; 2005 Feb; 124(2):412-8. PubMed ID: 15675962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
    Tosteson ANA; Tapp S; Titus LJ; Nelson HD; Longton GM; Bronson M; Pepe M; Carney PA; Onega T; Piepkorn MW; Knezevich SR; Barnhill R; Weinstock MA; Elder DE; Elmore JG
    JAMA Dermatol; 2021 Sep; 157(9):1102-1106. PubMed ID: 34076664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up.
    Gerami P; Busam K; Cochran A; Cook MG; Duncan LM; Elder DE; Fullen DR; Guitart J; LeBoit PE; Mihm MC; Prieto VG; Rabkin MS; Scolyer RA; Xu X; Yun SJ; Obregon R; Yazdan P; Cooper C; Weitner BB; Rademaker A; Barnhill RL
    Am J Surg Pathol; 2014 Jul; 38(7):934-40. PubMed ID: 24618612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    Takai S; Arai E; Shojiguchi N; Nakamura Y; Momose S; Fukuda T; Ishizawa K; Ogata D; Tsunemi Y; Nakamura K; Tsuchida T
    J Dermatol; 2023 May; 50(5):637-645. PubMed ID: 36539950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.
    Grilley-Olson JE; Hayes DN; Moore DT; Leslie KO; Wilkerson MD; Qaqish BF; Hayward MC; Cabanski CR; Yin X; Socinski MA; Stinchcombe TE; Thorne LB; Allen TC; Banks PM; Beasley MB; Borczuk AC; Cagle PT; Christensen R; Colby TV; Deblois GG; Elmberger G; Graziano P; Hart CF; Jones KD; Maia DM; Miller CR; Nance KV; Travis WD; Funkhouser WK
    Arch Pathol Lab Med; 2013 Jan; 137(1):32-40. PubMed ID: 22583114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
    Massi D; Szumera-Ciećkiewicz A; Alos L; Simi S; Ugolini F; Palmieri G; Stanganelli I; Cook MG; Mandalà M
    Eur J Cancer; 2023 Aug; 189():112921. PubMed ID: 37280145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
    Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
    Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
    Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
    J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
    Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.